Product Code: LS12238
According to the market research study published by P&S Intelligence, global single-use negative-pressure wound therapy devices market value, which was $770.2 million in 2020, is set to witness an 8.1% CAGR between 2020 and 2030, to reach $1,673.1 million by 2030.
The strongest factors leading to the market advance are:
- Rising Incidence of Burns: Every year, almost 180,000 people succumb to burn injures, says the World Health Organization (WHO). Additionally, such incidents are also a key reason behind disability-adjusted life years (DALY), which is propelling the demand for NPWT, an advanced wound care technique.
- Increasing Number of Diabetics: The increasing prevalence of diabetes is another driver for the single-use NPWT devices market advance because it often leads to diabetic foot ulcers, a type of chronic wound that is difficult to cure via traditional wound healing products. As per the International Diabetes Federation (IDF), the worldwide diabetes incidence in the age group of 20-79 will rise from 463 million in 2019 to 700 million in 2045.
Due to the lockdowns initiated and shift seen in the focus of the worldwide healthcare fraternity during the COVID-19 pandemic, the single-use NPWT devices market was negatively affected. This led to the reduced manufacturing and trade of such products, as well as their lower adoption due to the closure of many clinics, surgery departments, and burns units. But, since the lifting of the lockdowns and resumption of manufacturing operations and medical facilities, the market has been growing again.
The highest single-use NPWT devices market CAGR in the coming years, under the application segment, is set to be seen in the surgical wounds category. As surgeries often lead to post-operative wounds, the demand for single-use NPWT devices is rising among patients recovering at home or those with restricted mobility. In this regard, the rising volume of Caesarean section surgeries is propelling the market growth by driving the demand for wound healing products that can minimize the chances of post-op infection.
North America held the largest share in the single-use NPWT devices market in the past on account of the existence of numerous market players, rising spending on healthcare, and extensive research and development (R&D) in advanced wound care.
The most-significant global single-use NPWT devices market players include: Devon International Group, Smith & Nephew plc, ConvaTec Group plc, Molnlycke Health Care AB, Talley Group Limited, Acelity L.P. Inc., Cardinal Health Inc., Lohmann & Rauscher GmbH & Co. KG, Medela AG, Carilex Medical GmbH, Genadyne Biotechnologies Inc., TRIAGE MEDITECH PVT. LTD., and Paul Hartmann AG.
Table of Contents
Chapter 1. Research Background
- 1.1 Research Objectives
- 1.2 Market Definition
- 1.3 Research Scope
- 1.3.1 Market Segmentation by Application
- 1.3.2 Market Segmentation by End User
- 1.3.3 Market Segmentation by Region
- 1.3.4 Analysis Period
- 1.3.5 Market Data Reporting Unit
- 1.4 Key Stakeholders
Chapter 2. Research Methodology
- 2.1 Secondary Research
- 2.1.1 Paid
- 2.1.2 Unpaid
- 2.1.3 P&S Intelligence Database
- 2.2 Primary Research
- 2.2.1 Breakdown of Primary Research Respondents
- 2.2.1.1 By region
- 2.2.1.2 By industry participant
- 2.2.1.3 By company type
- 2.3 Market Size Estimation
- 2.4 Data Triangulation
- 2.5 Assumptions for the Study
Chapter 3. Executive Summary
Chapter 4. Introduction
- 4.1 Definition of Market Segments
- 4.1.1 By Application
- 4.1.1.1 Surgical wounds
- 4.1.1.2 Lacerations
- 4.1.1.3 Burns
- 4.1.1.4 Pressure ulcers
- 4.1.1.5 Venous ulcers
- 4.1.1.6 Diabetic ulcers
- 4.1.1.7 Others
- 4.1.2 By End User
- 4.1.2.1 Hospitals
- 4.1.2.2 Home-care settings
- 4.1.2.3 Others
- 4.2 Market Dynamics
- 4.2.1 Trends
- 4.2.1.1 Shift in preference toward advanced wound therapies
- 4.2.2 Drivers
- 4.2.2.1 Increasing cases of burns
- 4.2.2.2 Rising prevalence of diabetes
- 4.2.2.3 Growing geriatric population
- 4.2.2.4 High rate of C-section surgeries leading to increasing post-operative usage of single-use NPWT devices
- 4.2.2.5 Impact analysis of drivers on market forecast
- 4.2.3 Restraints
- 4.2.3.1 Availability of substitutes
- 4.2.3.2 Complications associated with single-use NPWT devices
- 4.2.3.3 Impact analysis of restraints on market forecast
- 4.2.4 Opportunities
- 4.2.4.1 Adoption of Single-use NPWT devices in low- and middle-income and war affected nations
- 4.2.4.2 Improving economic status of countries
- 4.3 Impact of COVID-19 on Single-Use NPWT Devices Market
- 4.4 Porter's Five Forces Analysis
- 4.5 Regulatory Scenario
- 4.5.1 North America
- 4.5.2 Europe
- 4.5.3 APAC
- 4.6 Comparison of NPWT and Conventional Wound Therapies
- 4.7 Reimbursement Policies
- 4.7.1 Healthcare Common Procedure Coding System (HCPCS) Codes
- 4.7.1.1 Current procedural technology (CPT) codes
Chapter 5. Global Market Size and Forecast
- 5.1 By Application
- 5.2 By End User
- 5.3 By Region
Chapter 6. North America Market Size and Forecast
- 6.1 By Application
- 6.2 By End User
- 6.3 By Country
- 6.3.1 U.S. Market Size and Forecast
- 6.3.1.1 By application
- 6.3.1.2 By end user
- 6.3.2 Canada Market Size and Forecast
- 6.3.2.1 By application
- 6.3.2.2 By end user
Chapter 7. Europe Market Size and Forecast
- 7.1 By Application
- 7.2 By End User
- 7.3 By Country
- 7.3.1 Germany Market Size and Forecast
- 7.3.1.1 By application
- 7.3.1.2 By end user
- 7.3.2 France Market Size and Forecast
- 7.3.2.1 By application
- 7.3.2.2 By end user
- 7.3.3 U.K. Market Size and Forecast
- 7.3.3.1 By application
- 7.3.3.2 By end user
- 7.3.4 Italy Market Size and Forecast
- 7.3.4.1 By application
- 7.3.4.2 By end user
- 7.3.5 Spain Market Size and Forecast
- 7.3.5.1 By application
- 7.3.5.2 By end user
- 7.3.6 Russia Market Size and Forecast
- 7.3.6.1 By application
- 7.3.6.2 By end user
Chapter 8. APAC Market Size and Forecast
- 8.1 By Application
- 8.2 By End User
- 8.3 By Country
- 8.3.1 China Market Size and Forecast
- 8.3.1.1 By application
- 8.3.1.2 By end user
- 8.3.2 Japan Market Size and Forecast
- 8.3.2.1 By application
- 8.3.2.2 By end user
- 8.3.3 India Market Size and Forecast
- 8.3.3.1 By application
- 8.3.3.2 By end user
- 8.3.4 Australia Market Size and Forecast
- 8.3.4.1 By application
- 8.3.4.2 By end user
- 8.3.5 South Korea Market Size and Forecast
- 8.3.5.1 By application
- 8.3.5.2 By end user
- 8.3.6 Indonesia Market Size and Forecast
- 8.3.6.1 By application
- 8.3.6.2 By end user
- 8.3.7 Sri Lanka Market Size and Forecast
- 8.3.7.1 By application
- 8.3.7.2 By end user
Chapter 9. LATAM Market Size and Forecast
- 9.1 By Application
- 9.2 By End User
- 9.3 By Country
- 9.3.1 Brazil Market Size and Forecast
- 9.3.1.1 By application
- 9.3.1.2 By end user
- 9.3.2 Mexico Market Size and Forecast
- 9.3.2.1 By application
- 9.3.2.2 By end user
Chapter 10. MEA Market Size and Forecast
- 10.1 By Application
- 10.2 By End User
- 10.3 By Country
- 10.3.1 South Africa Market Size and Forecast
- 10.3.1.1 By application
- 10.3.1.2 By end user
- 10.3.2 Saudi Arabia Market Size and Forecast
- 10.3.2.1 By application
- 10.3.2.2 By end user
- 10.3.3 U.A.E. Market Size and Forecast
- 10.3.3.1 By application
- 10.3.3.2 By end user
Chapter 11. Competitive Landscape
- 11.1 Market Share Analysis of Key Players
- 11.2 Strategic Developments of the Key Players
- 11.2.1 Mergers, Acquisitions, and Partnerships
- 11.2.2 Approvals and Product Launches
- 11.2.3 Other Developments
Chapter 12. Company Profiles
- 12.1 Devon International Group
- 12.1.1 Business Overview
- 12.1.2 Product and Service Offerings
- 12.2 ConvaTec Group plc
- 12.2.1 Business Overview
- 12.2.2 Product and Service Offerings
- 12.2.3 Key Financial Summary
- 12.3 Smith & Nephew plc
- 12.3.1 Business Overview
- 12.3.2 Product and Service Offerings
- 12.3.3 Key Financial Summary
- 12.4 Molnlycke Health Care AB
- 12.4.1 Business Overview
- 12.4.2 Product and Service Offerings
- 12.4.3 Key Financial Summary
- 12.5 Acelity L.P. Inc.
- 12.5.1 Business Overview
- 12.5.2 Product and Service Offerings
- 12.6 Talley Group Limited
- 12.6.1 Business Overview
- 12.6.2 Product and Service Offerings
- 12.7 Cardinal Health Inc.
- 12.7.1 Business Overview
- 12.7.2 Product and Service Offerings
- 12.7.3 Key Financial Summary
- 12.8 Medela AG
- 12.8.1 Business Overview
- 12.8.2 Product and Service Offerings
- 12.9 Lohmann & Rauscher GmbH & Co. KG
- 12.9.1 Business Overview
- 12.9.2 Product and Service Offerings
- 12.10 Carilex Medical GmbH
- 12.10.1 Business Overview
- 12.10.2 Product and Service Offerings
- 12.11 TRIAGE MEDITECH PVT. LTD.
- 12.11.1 Business Overview
- 12.11.2 Product and Service Offerings
- 12.12 Genadyne Biotechnologies Inc.
- 12.12.1 Business Overview
- 12.12.2 Product and Service Offerings
- 12.13 Paul Hartmann AG
- 12.13.1 Business Overview
- 12.13.2 Product and Service Offerings
- 12.13.3 Key Financial Summary
Chapter 13. Appendix
- 13.1 Abbreviations
- 13.2 Sources and References
- 13.3 Related Reports